Home > Annual Financials > INDRAYANI BIOTECH

INDRAYANI BIOTECH Financial Statement Analysis
[BOM: 526445]

The Revenues of INDRAYANI BIOTECH have increased by 2.02% YoY .
The Earnings Per Share (EPS) of INDRAYANI BIOTECH has decreased by -45.10 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

INDRAYANI BIOTECH Last 5 Annual Financial Results
[BOM: 526445]

ConsolidatedMar2024
Mar2023
Mar2022
Mar2021
Mar2020
Revenues ₹166 Cr₹163 Cr₹62 Cr₹21 Cr₹50 Cr
Expenses ₹143 Cr₹146 Cr₹55 Cr₹26 Cr₹47 Cr
Operating Profit (Excl OI) ₹24 Cr₹17 Cr₹6.78 Cr₹-4.94 Cr₹2.78 Cr
Other Income ₹1.22 Cr₹4.49 Cr₹0.22 Cr₹0.27 Cr₹0.20 Cr
Interest ₹10 Cr₹5.64 Cr₹1.89 Cr₹1.97 Cr₹1.15 Cr
Depreciation ₹3.80 Cr₹3.35 Cr₹0.66 Cr₹0.46 Cr₹1.01 Cr
Profit Before Tax ₹11 Cr₹12 Cr₹4.44 Cr₹-11 Cr₹0.81 Cr
Profit After Tax ₹10 Cr₹12 Cr₹4.44 Cr₹-11 Cr₹0.81 Cr
Consolidated Net Profit ₹6.37 Cr₹8.74 Cr₹4.44 Cr₹-11 Cr₹0.81 Cr
Earnings Per Share (Rs)₹1.40₹2.55₹1.30₹-3.25₹2.22
PAT Margin (%)6.277.327.21-53.181.62
ROE(%)19.4134.8620.23-112.2943.42
ROCE(%)14.4022.4516.38-23.167.85
Total Debt/Equity(x)1.711.170.740.7954.18

Key Financials

Market Cap : ₹ 180.2 Cr
Revenue (TTM) : ₹ 155.4 Cr
Net Profit(TTM) : ₹ 12.2 Cr
EPS (TTM) : ₹ 2.7
P/E (TTM) : 14.8

Industry Peers & Returns1W1M1Y
INDRAYANI BIOTECH -4.4% -12.4% -33%


No other companies found in this Industry


INDRAYANI BIOTECH Revenues
[BOM: 526445]

Y-o-Y

2.02 %

5 Yr CAGR

35.10 %

Years Revenues % Change
Mar2024 ₹166 Cr
2.02
Mar2023 ₹163 Cr
164.61
Mar2022 ₹62 Cr
191.98
Mar2021 ₹21 Cr
-57.74
Mar2020 ₹50 Cr -


INDRAYANI BIOTECH Operating Profit
[BOM: 526445]

Y-o-Y

36.67 %

5 Yr CAGR

70.84 %

Years Operating Profit % Change
Mar2024 ₹24 Cr
36.67
Mar2023 ₹17 Cr
155.26
Mar2022 ₹6.78 Cr
Positive
Mar2021 ₹-4.94 Cr
Negative
Mar2020 ₹2.78 Cr -

Operating Margins
Y-o-Y

33.99 %

5 Yr CAGR

26.43 %

Years Operating Margin% % Change
Mar2024 14.23%
33.99
Mar2023 10.62%
-3.54
Mar2022 11.01%
Positive
Mar2021 -23.44%
Negative
Mar2020 5.57% -

INDRAYANI BIOTECH Profit After Tax
[BOM: 526445]

Y-o-Y

-27.15 %

5 Yr CAGR

67.58 %

Years Profit After Tax % Change
Mar2024 ₹6.37 Cr
-27.15
Mar2023 ₹8.74 Cr
96.78
Mar2022 ₹4.44 Cr
Positive
Mar2021 ₹-11 Cr
Negative
Mar2020 ₹0.81 Cr -

PAT Margins
Y-o-Y

-14.34 %

5 Yr CAGR

40.26 %

Years PAT Margin(%) % Change
Mar2024 6.27 %
-14.34
Mar2023 7.32 %
1.53
Mar2022 7.21 %
Positive
Mar2021 -53.18 %
Negative
Mar2020 1.62 % -

INDRAYANI BIOTECH Earnings Per Share (EPS)
[BOM: 526445]

Y-o-Y

-45.10 %

5 Yr CAGR

-10.89 %

Years EPS % Change
Mar2024 ₹1.40
-45.10
Mar2023 ₹2.55
96.15
Mar2022 ₹1.30
Positive
Mar2021 ₹-3.25
Negative
Mar2020 ₹2.22 -

INDRAYANI BIOTECH Return on Capital Employed (ROCE)
[BOM: 526445]

Y-o-Y

-35.86 %

5 Yr CAGR

16.38 %

Years ROCE % Change
Mar2024 14.4%
-35.86
Mar2023 22.45%
37.06
Mar2022 16.38%
Positive
Mar2021 -23.16%
Negative
Mar2020 7.85% -

INDRAYANI BIOTECH Share Price vs Sensex

Current Share Price : ₹39.6
Current MarketCap: ₹ 180.2 Cr
Updated EOD on :Oct 17,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
INDRAYANI BIOTECH

-4.4%

-12.4%

-33%

SENSEX

-0.7%

-2.4%

22%

INDRAYANI BIOTECH related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about INDRAYANI BIOTECH Financials


How the annual revenues of INDRAYANI BIOTECH have changed ?

The Revenues of INDRAYANI BIOTECH have increased by 2.02% YoY .

How the Earnings per Share (EPS) of INDRAYANI BIOTECH have changed?

The Earnings Per Share (EPS) of INDRAYANI BIOTECH has decreased by -45.10 % YoY .

Check out Intrinsic Value of Peers of INDRAYANI BIOTECH
Intrinsic Value of INDRAYANI BIOTECH LTD

Compare Stock Analytics of Peers of INDRAYANI BIOTECH
No other companies found in this Industry